ArticleDiabetes care2019

Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride.

Elisabetta Patorno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.